TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0 an...
FDA Device Recall #Z-1617-2020 — Class II — February 19, 2020
Recall Summary
| Recall Number | Z-1617-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 19, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Haemonetics Corporation |
| Location | Boston, MA |
| Product Type | Devices |
| Quantity | 88 units |
Product Description
TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0 and 4.1.1. Intended: For in vitro coagulation studies
Reason for Recall
Software defect in TEG Manager impacts the displayed alert for out of range test results. Due to this defect, reference range values received from TEG 5000 and displayed on the TEG Manager test result screen are rounded to the nearest whole number and lead to TEG Manager displaying an out of range alert when the test result is actually in range, or vice versa.
Distribution Pattern
US Nationwide distribution.
Lot / Code Information
TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0, and 4.1.1.
Other Recalls from Haemonetics Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1310-2022 | Class II | TEG 5000 Functional Fibrinogen Reagent, Item No... | Apr 26, 2022 |
| Z-1298-2022 | Class II | Product Name: TEG5000 Analyzer (07-022, 07-033)... | Apr 19, 2022 |
| Z-0904-2020 | Class II | JAPAN CELL SAVER ELITE SET - 225ML - Product Us... | Oct 21, 2019 |
| Z-0890-2020 | Class II | CS5/5+ Fastpacks, 225 mL, 20¿ Res Autotransfusi... | Oct 21, 2019 |
| Z-0900-2020 | Class II | JAPAN DISP SET, 261J, 205J, HAR - Product Usage... | Oct 21, 2019 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.